As of 2025-07-20, the Intrinsic Value of Guangzhou Wondfo Biotech Co Ltd (300482.SZ) is 15.11 CNY. This 300482.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 22.06 CNY, the upside of Guangzhou Wondfo Biotech Co Ltd is -31.50%.
The range of the Intrinsic Value is 11.50 - 23.17 CNY
Based on its market price of 22.06 CNY and our intrinsic valuation, Guangzhou Wondfo Biotech Co Ltd (300482.SZ) is overvalued by 31.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 11.50 - 23.17 | 15.11 | -31.5% |
| DCF (Growth 10y) | 16.91 - 34.78 | 22.49 | 1.9% |
| DCF (EBITDA 5y) | 53.96 - 79.62 | 68.86 | 212.2% |
| DCF (EBITDA 10y) | 52.28 - 87.70 | 70.67 | 220.3% |
| Fair Value | 23.95 - 23.95 | 23.95 | 8.59% |
| P/E | 28.96 - 40.59 | 34.97 | 58.5% |
| EV/EBITDA | 28.58 - 39.74 | 34.30 | 55.5% |
| EPV | 12.23 - 17.27 | 14.75 | -33.1% |
| DDM - Stable | 7.23 - 20.62 | 13.92 | -36.9% |
| DDM - Multi | 12.34 - 28.59 | 17.38 | -21.2% |
| Market Cap (mil) | 10,620.12 |
| Beta | 1.58 |
| Outstanding shares (mil) | 481.42 |
| Enterprise Value (mil) | 10,407.61 |
| Market risk premium | 6.13% |
| Cost of Equity | 10.77% |
| Cost of Debt | 5.00% |
| WACC | 10.42% |